- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02431741
A Prospective, Open, Non-controlled Clinical Investigation to Evaluate the Performance and Safety of an Antimicrobial Foam Transferring Dressing in Patients With Malignant Wounds
April 18, 2017 updated by: Molnlycke Health Care AB
Title: A Prospective, Open, Non-controlled Clinical Investigation to Evaluate the Performance and Safety of an Antimicrobial Foam Transferring Dressing in Patients With Malignant Wounds
This is a prospective, open, non-controlled clinical investigation to evaluate the performance and safety of using Mepilex Transfer Ag on a malignant wound.
Approximately ten to fifteen (10-15) subjects from one to three centers in Europe, presenting with a malignant (fungating) wound will be enrolled into the study.
Eligible subjects will have one malignant (fungating) wound selected as a "study site".
Subjects will be followed for a one-week observation period with their existing product followed by a 4-week investigation period using Mepilex Transfer Ag.
Study Overview
Study Type
Interventional
Enrollment (Actual)
14
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Prague, Czech Republic
- The General University Hospital in Prague
-
Prague, Czech Republic
- Charles University School of Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Presence of at least one exuding malignant (fungating) wound in need for antimicrobial treatment
- Both genders with an age ≥ 18 years at randomization
- Subjects with a suspected survival time of > 3 months
- Signed informed consent
Exclusion Criteria:
- Any known or suspected systemic infection
- Use of metronidazole is not allowed during the investigation period
- Any known sensitivity to silver or other components/products used in this study.
- Major uncontrolled systemic disorders such as hepatic, renal, neurologic, or endocrinologic disorders.
- Participation in another investigational study while participating in this study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Mepilex Transfer Ag
Non controlled investigation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Infection in the Wound (Signs of Clinical Infection)
Time Frame: weekly, for 5 weeks
|
Weekly Visual inspection of the wounds by the investigators.
|
weekly, for 5 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2014
Primary Completion (Actual)
August 1, 2015
Study Completion (Actual)
December 1, 2015
Study Registration Dates
First Submitted
April 28, 2015
First Submitted That Met QC Criteria
April 30, 2015
First Posted (Estimate)
May 1, 2015
Study Record Updates
Last Update Posted (Actual)
April 25, 2017
Last Update Submitted That Met QC Criteria
April 18, 2017
Last Verified
April 1, 2015
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- MxT Ag 03
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Malignant Wounds
-
Rigshospitalet, DenmarkCompletedCancer | Malignant WoundsDenmark
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Malignant Solid Neoplasm | Metastatic Malignant Neoplasm in the SpineUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingMalignant Solid Neoplasm | Hematopoietic and Lymphoid System NeoplasmUnited States
-
Assistance Publique - Hôpitaux de ParisRecruitingMalodorous Wounds (Chronic, Malignant or Infected Wounds)France
-
Rutgers, The State University of New JerseyTerminatedBenign/Malignant Neoplasm | Long Bone FractureUnited States
-
M.D. Anderson Cancer CenterMerck Sharp & Dohme LLCCompletedHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid NeoplasmUnited States
-
Instituto de Investigación Hospital Universitario...Universidad Autonoma de MadridRecruiting
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingMalignant Fungating WoundChina
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedMetastatic Malignant Neoplasm | Unresectable Malignant Neoplasm | Advanced Malignant NeoplasmUnited States
-
National Cancer Institute (NCI)Active, not recruitingAdvanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Unresectable Malignant Solid Neoplasm | Metastatic Malignant Solid NeoplasmUnited States
Clinical Trials on Mepilex Transfer Ag
-
Molnlycke Health Care ABCompleted
-
Molnlycke Health Care ABCompletedDonor Site ComplicationUnited States
-
Molnlycke Health Care ABCompleted
-
Molnlycke Health Care ABCompletedBurn Injury | Skin GraftUnited States
-
Molnlycke Health Care ABCompletedVenous Leg Ulcers | Mixed Leg UlcersFrance, Germany, Netherlands, Czech Republic
-
The University of Texas Medical Branch, GalvestonWithdrawnPartial-thickness BurnUnited States
-
Stedical Scientific, Inc.RecruitingThermal BurnUnited States
-
Aubrey Inc.TerminatedBurn SurgeryUnited States
-
MiMedx Group, Inc.TerminatedTreatment of Partial Thickness BurnsUnited States
-
Molnlycke Health Care ABCompleted